Project Grant H8G48837

This $5,358,220 Cooperative Agreement award from the Centers for Disease Control and Prevention (CFDA 93.354 - Public Health Emergency Response: Cooperative Agreement for Emergency Response) will support the Hawaii Department of Health in increasing vaccination rates across the state, with a focus on populations disproportionately affected by MPOX. The funding will enable the department to establish and maintain a cross-functional workgroup to develop and implement education and outreach...

The National Science Foundation (NSF) awarded a $997,689 Cooperative Agreement under its NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Omnicyte LLC, a minority-owned small business in Branford, CT. The funding supports the design and production of a next-generation COVID-19 vaccine that addresses weaknesses of current vaccines, such as reduced booster effectiveness, short-lived efficacy, and side effects. The project aims to develop a vaccine candidate with improved...

This $3,287,846 Cooperative Agreement awarded by the Centers for Disease Control and Prevention (CDC) under CFDA 93.185 "Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects" supports the American Immunization Registry Association in enhancing immunization information systems. The 5-year award, running from August 1, 2024 to July 31, 2029, will enable comprehensive public health initiatives related to...

This Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $7,994,888 to establish the Research and Development of Vaccines and Antibodies for Pandemic Preparedness (REVAMPP) Coordinating and Data Sharing Center (CDSC). The CDSC, led by Research Triangle Institute (RTI) International, will coordinate and facilitate a collaborative research network to accelerate the...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $534,242 to the New York Blood Center, Inc. to study the immune and behavioral responses of transgender women to the updated seasonal COVID-19 vaccines. The study aims to understand the impact of gender-affirming hormone therapy on immune responses and factors influencing vaccine uptake in this population. The award will...

This is a Cooperative Agreement awarded by the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283). The $1,980,000 award is to Jhpiego Corp, a non-profit global health organization affiliated with Johns Hopkins University, to strengthen immunization program implementation in the Philippines over a 5-year period from Sep 30, 2024 to Sep 29, 2029. The key products and services to be delivered under this Cooperative...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $684,241 Cooperative Agreement under CFDA 93.185 "Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects" to the New Hampshire Department of Health & Human Services (NH DHHS). The funding will support comprehensive public health initiatives related to vaccine-preventable diseases, enabling research, demonstration projects, and public information...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $228,825 to New York University (NYU) School of Medicine to conduct research focused on developing an effective HIV vaccine. The key objectives are to: 1) Design and validate a vaccine immunogen targeting the V2B neutralization epitope on the HIV/SIV viral spike, and 2) Test the combination of vaccine-elicited antibodies...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $2,346,429 Cooperative Agreement grant to the Maine Department of Health and Human Services (Maine DHHS) on August 1, 2024. This 5-year grant under CFDA Program 93.185 "Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects" will support comprehensive public health initiatives related to vaccine-preventable diseases in Maine. The funding will enable...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $1.3M Cooperative Agreement under the CDC Investigations and Technical Assistance program (CFDA 93.283) to the Albert B. Sabin Vaccine Institute, Inc. The award will support strengthening immunization program implementation in consequential sub-national geographical areas of Brazil over a 5-year period from September 2024 to September 2029. The Cooperative Agreement aims to enhance disease detection and response capabilities,...